45. IV ketamine for TRD patients who have failed to respond to transcranial magnetic stimulation

Intravenous ketamine for treatment-resistant depression patients who have failed to respond to transcranial magnetic stimulation: A case series

Olivier Payette, Paul Lespérance, Véronique Desbeaumes Jodoin, Christophe Longpré-Poirier, Laurent Elkrief, Maxime Richard, Nicolas Garel, Jean-Philippe Miron.
J Affect Disord. 2023 Apr 17;333:18-20. doi: 10.1016/j.jad.2023.04.019. Epub ahead of print. PMID: 37075822.

Presenter: Jean-Philippe Miron, MD, PhD, FRCPC Psychiatrist, Psychiatric Neuromodulation Unit (UNP), University of Montreal Hospital Center (CHUM) Assistant Clinical Professor, Department of Psychiatry and Addictology, Faculty of Medicine, University of Montreal Principal Scientist, CHUM Research Center (CRCHUM), Montreal, Quebec, Canada

Date: 27.06.2023